GrantNIH REPORTERMay 11
Researchers are developing a new blood test that can detect tiny pieces of cancer DNA floating in the bloodstream to catch lung cancer early. Instead of invasive procedures like biopsies or CT scans, this simple blood test could help doctors find lung cancer sooner and monitor how well treatment is working. The National Institutes of Health is funding this $415,000 research project starting in 2026.
WHY IT MATTERSFor lung cancer patients, this blood-based test could enable earlier detection when treatment is most effective and reduce the need for invasive biopsies or repeated imaging scans.
ResearchRSSMay 7
Researchers found that a special type of food supplement called a prebiotic can help restore healthy bacteria in the guts of people with Parkinson's disease. Even better, they discovered a simple blood test that can measure tiny particles to show whether the treatment is working. This blood test tracks signals that travel between the gut and the brain.
WHY IT MATTERSFor Parkinson's patients, this offers a non-invasive way to monitor whether gut-targeted treatments are actually working, potentially opening a new avenue for managing symptoms through gut health.
ResearchPUBMEDMay 1
Researchers studied whether the placebo effect (feeling better just because you expect to) is a real problem in rare disease trials where patients serve as their own comparison group. They found that for objective measurements like blood tests and imaging scans—which are used in most approved rare disease treatments—the placebo effect is very small and usually not a major concern.
WHY IT MATTERSIf you're considering enrolling in a rare disease trial using a patient-as-own-control design, this research shows that the results are likely measuring real treatment effects rather than just placebo effects, making the trial data more trustworthy for evaluating whether a treatment actually works.
ResearchRSSApr 29
Corvista Health and Mayo Clinic are working together to test a new blood test that could help doctors diagnose pulmonary hypertension (a serious lung disease where blood pressure in the lungs gets too high) without invasive procedures. The test aims to make it easier to identify who has the disease, figure out how severe it is, and decide who needs to see a specialist. This collaboration is an important step forward in developing better diagnostic tools for this condition.
WHY IT MATTERSIf successful, this non-invasive test could help patients with suspected pulmonary hypertension get diagnosed faster and more accurately, potentially avoiding unnecessary invasive procedures like heart catheterization while ensuring those who need specialist care are properly referred.
ResearchBIORXIVApr 20
Researchers analyzed blood samples from over 5,400 people with rare genetic diseases to see if a test called RNA-Seq could help find the genetic cause of their conditions. They found that this blood test works better for some diseases than others, and they used special computer programs to spot unusual gene activity patterns that might explain why people got sick. This study shows that blood tests could be a useful tool to help diagnose rare diseases alongside other genetic tests.
WHY IT MATTERSIf you have an undiagnosed rare disease, this research suggests blood-based RNA testing could help identify the genetic cause—potentially leading to a diagnosis after years of searching.
ResearchPUBMEDMar 26
Doctors found a rare lung disease called pulmonary light chain deposition disease (PLCDD) that creates cysts and bumps in the lungs. This disease is hard to diagnose because it looks similar to other lung conditions, but special imaging scans and blood tests for abnormal proteins can help identify it. The article explains how doctors should think about this disease when patients have unusual cyst patterns in their lungs.
WHY IT MATTERSIf you have been diagnosed with an unusual cystic lung disease that doesn't fit typical patterns, your doctor should consider testing for light chain deposition disease, which requires specific blood work and imaging to confirm.
ResearchPUBMEDMar 26
Researchers tested new ways to help more diverse groups of people join rare disease genetic studies. They used strategies like having doctors refer patients, providing language support, and bringing blood tests to people's homes. About 83% of people they tried to recruit successfully joined the study, showing these methods work well.
WHY IT MATTERSIf you or your family member has a rare disease and belongs to a group that has been underrepresented in genetic research, this work means future studies are more likely to actively recruit and support your participation, potentially leading to better understanding of your condition.
Clinical trialCLINICALTRIALSMar 26
Researchers at the National Heart, Lung, and Blood Institute are looking for 5,000 people who have or might have diseases that affect their heart, blood vessels, or metabolism. Participants will have blood tests and heart function tests tailored to their specific condition. Both people with these conditions and healthy people can join to help scientists understand why some people develop heart disease.
WHY IT MATTERSThis large-scale study is actively recruiting and may help identify new risk factors for heart disease in people with rare metabolic, inflammatory, and genetic conditions like Li-Fraumeni Syndrome and cardiomyopathy.